Real Estate / Life Science REITTechnical Analysis Guide

ARE Stock Analysis

Alexandria Real Estate Equities, Inc.

💡 Quick Answer

Across 4 APEX technical signals, ARE is currently split between bullish and bearish readings — 0 bullish, 0 bearish as of 2026-06-11. Run a live analysis to see the current composite score.

ARE runs ATR of 2-3.5% and trades on the 10-year yield, lab-space supply/demand, and biotech-funding sentiment. It has been pressured by lab oversupply and rate concerns.

RSI Behavior: Rate + sector 35-68MACD Pattern: Rate and leasing drivenMoving Average: 200-day rate proxy

Alexandria owns and develops life-science and lab space in top biotech cluster markets (Boston, San Francisco, San Diego). Demand tracks biotech funding and pharma R&D, with new lab supply and tenant credit as the recent overhangs.

LIVE CHART·ARE. DailyPowered by TradingView

📊 Open ARE on TradingView ↗Affiliate link

Get live ARE signal analysis

APEX runs 8 signals on ARE in real time: RSI, MACD, Fibonacci, Volume, and more.

Analyze ARE Now →

Why Do Traders Watch ARE?

ARE runs ATR of 2-3.5% and trades on the 10-year yield, lab-space supply/demand, and biotech-funding sentiment. It has been pressured by lab oversupply and rate concerns. Leasing trends drive the earnings reaction.

Is ARE a Buy Right Now? Current Signal Readings

📊RSI BehaviorRate + sector 35-68

RSI moves inverse to rates and tracks biotech-funding sentiment. Sub-40 readings on lab-supply fears have been deep-value entries when leasing held.

📈MACD PatternRate and leasing driven

MACD tracks rates plus lab-leasing momentum. The weekly frames the supply-absorption trend.

📊Moving Average200-day rate proxy

The 200-day frames the regime. Reclaiming it on leasing recovery and rate relief has marked sentiment turns.

📦Volume ProfileRate and earnings

Volume rises on rate days and earnings where leasing activity and occupancy drive the move.

📋 ARE Key Stats for Traders

⚡ATR (14-day)2-3.5% of price

📦Avg daily volume~1.5-2.5 million shares

🎯Key metricLab leasing + occupancy

⚠️Risk levelMedium (rate + sector)

🔗 Related Stocks

BXPKRCDOCO

Run a live ARE analysis

APEX combines RSI, MACD, Fibonacci, Volume, and 4 more signals into one composite score in under 30 seconds.

Analyze ARE Free →

📊 Advanced charting for ARE on TradingView ↗

💬 Frequently Asked Questions. ARE

QIs ARE a good stock to buy right now?

AWhether ARE is a buy depends on its current technical positioning. ARE runs ATR of 2-3.5% and trades on the 10-year yield, lab-space supply/demand, and biotech-funding sentiment. It has been pressured by lab oversupply and rate concerns. Leasing trends drive the earnings reaction. Run a live APEX analysis at apexstockintel.com to see the current composite score, RSI, and MACD signals. Updated every trading day.

QWhat are the most important technical signals for ARE?

AThe four key signals for ARE are: RSI Behavior (Rate + sector 35-68). RSI moves inverse to rates and tracks biotech-funding sentiment. Sub-40 readings on lab-supply fears have been deep-value entries when leasing held.. MACD Pattern (Rate and leasing driven). MACD tracks rates plus lab-leasing momentum. The weekly frames the supply-absorption trend.. Moving Average (200-day rate proxy). The 200-day frames the regime. Reclaiming it on leasing recovery and rate relief has marked sentiment turns.. Volume Profile (Rate and earnings). Volume rises on rate days and earnings where leasing activity and occupancy drive the move.

QWhat is ARE's RSI telling traders right now?

ARSI moves inverse to rates and tracks biotech-funding sentiment. Sub-40 readings on lab-supply fears have been deep-value entries when leasing held. APEX scores ARE's RSI as part of its 8-factor composite signal. Updated daily.

QHow does ARE behave technically compared to other Real Estate / Life Science REIT stocks?

AARE is in the Real Estate / Life Science REIT sector. Alexandria owns and develops life-science and lab space in top biotech cluster markets (Boston, San Francisco, San Diego). Demand tracks biotech funding and pharma R&D, with new lab supply and tenant credit as the recent overhangs. Key stats: ATR (14-day): 2-3.5% of price, Avg daily volume: ~1.5-2.5 million shares, Key metric: Lab leasing + occupancy, Risk level: Medium (rate + sector).

QWhat MACD signals work best for ARE?

AMACD tracks rates plus lab-leasing momentum. The weekly frames the supply-absorption trend.

OTHER STOCK GUIDES

Technology49

+−